ライフサイエンスコーパス: DAMP

1 DAMP recognition by dendritic cells (DCs) has also been

2 DAMPs are endogenous molecules that are actively secrete

3 DAMPs are recognized by the innate immune system via pat

4 DAMPs encompass a group of heterogenous molecules, inclu

5 DAMPs represent a heterogeneous group of molecules that

6 DAMPs trigger innate immunity by activating Toll-like re

7 DAMPs within the tumor microenvironment stimulate tumor-

8 observed that circulating levels of these 2 DAMPs are increased in hypertension, and activation of T

9 MP glucuronide, didesethyl PM, and hydroxy-2-DAMP glucuronide) were tentatively identified in differe

10 ould be identified; two known metabolites (2-DAMP and N-desethyl PM) were confirmed with a standard,

11 reas three previously unknown metabolites (2-DAMP glucuronide, didesethyl PM, and hydroxy-2-DAMP gluc

12 4-DAMP inhibited neurogenic secretion by 80 and 95%, respe

13 and blocked by atropine methylbromide and 4-DAMP mustard, an M(3) muscarinic receptor selective anta

14 5.0 nM for telenzepine, methoctramine and 4-DAMP, respectively.

15 elective muscarinic M3 receptor antagonist 4-DAMP (100 nmol/L) but was blocked by the M2 receptor ant

16 The M3 mAChR antagonist 4-DAMP abolished the stimulatory effect of oxotremorine-M

17 The M3 muscarinic receptor antagonist 4-DAMP effectively reversed muscarine-induced inhibition o

18 s inhibited by the m3 receptor antagonist, 4-DAMP, and binding to Galphai3 antibody was inhibited by

19 In contrast, the M3-selective antagonist, 4-DAMP-mustard, blocked muscarinic excitations in a majori

20 activity was also completely inhibited by 4-DAMP in both species.

21 potentials (EJP) were partially blocked by 4-DAMP in half of the cells tested.

22 y gallamine (10(-5) M), and 72% +/- 11% by 4-DAMP mustard (10(-5) M).

23 dispersed muscle cells was accentuated by 4-DAMP or Gbeta antibody (55 +/- 8 to 63 +/- 6%).

24 6%); the increase in cAMP was abolished by 4-DAMP or Gbeta antibody.

25 yperpolarization was reversibly blocked by 4-DAMP, charybdotoxin or BAPTA-AM, but not by N(omega)-nit

26 an increase in cAMP that was abolished by 4-DAMP.

27 ts, identifying both rapidly dissociating (4-DAMP, himbacine) and slowly dissociating (tiotropium, gl

28 (3) receptor pathway was blocked by either 4-DAMP or by intracellular dialysis with anti-Galphaq anti

29 -(2-chloroethyl)-piperidine hydrochloride (4-DAMP mustard; M3) were incubated with carbachol to deter

30 -(2-chloroethyl)-piperidine hydrochloride (4-DAMP; 10(-5) M) for 10 minutes.

31 nylacetoxy-N-methyl-piperidine methiodide (4-DAMP) was 57-244-fold smaller than that of pirenzepine,

32 enylacetoxy-N-methylpiperidine methiodide (4-DAMP; M1 and M3).

33 ylacetoxy-N-methylpiperidine methobromide (4-DAMP) for the M3 receptor.

34 act cells, and the m3-mAChR selectivity of 4-DAMP and pFHHSiD was 2.4- and 3.9-fold less in membranes

35 The m3-mAChR selectivity of 4-DAMP in intact cells was unaffected by cytoskeletal depo

36 onses were blocked by atropine (10 mum) or 4-DAMP (100 nm), an M(3) receptor antagonist.

37 order of potency (atropine > pirenzepine = 4-DAMP >> gallamine) consistent with regulation by M1, rat

38 response curve to methoctramine but not to 4-DAMP, pirenzepine, or tropicamide.

39 y doubled the stimulated response, whereas 4-DAMP abolished the stimulated secretory response.

40 te monocytes via the toll-like receptor 3/7: DAMP axis.

41 Here we report that actin is also a DAMP in invertebrates that lack DCs and adaptive immunit

42 coding double-stranded RNA (dsRNAs) act as a DAMP in the skin and how the human cathelicidin AMP LL-3

43 ypothesis that OGs released in vivo act as a DAMP signal to trigger plant immunity and suggest that c

44 ased from necrotic liver cells and acts as a DAMP to mediate acetaminophen-induced liver injury.

45 As a DAMP, S100A4 is sensitive to oxidation whereas uric acid

46 the host response to DAMP is controlled by a DAMP-CD24-Siglec axis.

47 Actin is a DAMP detected in mammals by the receptor, DNGR-1, expres

48 Serum amyloid A (SAA) is a DAMP that is involved in the development of various chro

49 In summary, CypA is a DAMP that mediates acetaminophen poisoning.

50 uggest that under disease relevant acidosis, DAMPs and lactic acid induce the secretion of IL-1beta i

51 Although DAMPs such as endogenous DNA and nuclear high-mobility g

52 nose (PCAM), 1-deoxy-1-aminomannopyranoside (DAMP), glucosamine and low molecular weight chitosan bon

53 "pairing-priming") isothermal amplification (DAMP) assay for rapid nucleic acid detection with ultral

54 Microglia morphology and DAMP signaling in enriched rat hippocampal microglia wer

55 are whether and how the response to PAMP and DAMP are regulated differentially.

56 In addition, a role for PAMP and DAMP perception in bolstering effector-triggered immunit

57 ed as a potential target to treat stroke and DAMP- and PAMP-induced inflammation.

58 ltiple cytokines, tissue injury markers, and DAMPs were associated with persistent MODS.

59 Confirming our idea that both PAMPs and DAMPs are likely to cooccur at infection sites, cotreatm

60 Both PAMPs and DAMPs can be liberated by early insults to the allograft

61 symmetry in host responses between PAMPs and DAMPs extends to metabolic shifts is unclear.

62 The interactions of PAMPs and DAMPs require further investigation in dental/oral infla

63 Most PAMPs and DAMPs serve as so-called 'Signal 0s' that bind specific

64 age-associated molecular patterns (PAMPs and DAMPs) orchestrate inflammatory responses to infection a

65 rile injuries cause the release of PAMPs and DAMPs.

66 This work focuses on the Arabidopsis DAMPs plant elicitor peptides (Peps) and their receptors

67 tanding that oxidation-specific epitopes are DAMPs, and thus the target of multiple arcs of innate im

68 ctors, as well as unsolved questions such as DAMP release from non-tumor cells as well as the existen

69 demonstrated that both S100A4 and UA act as DAMPs and, as such, may play a critical role in promotin

70 report that endogenous histones function as DAMPs after ischemic injury through the pattern recognit

71 esis that bone matrix components function as DAMPs for the NLRP3 inflammasome and regulate osteoclast

72 additional signals such as aging-associated DAMPs.

73 irect toward strategies aimed at attenuating DAMP-mediated inflammation while preserving antimicrobia

74 the increasingly complex connection between DAMPs and kidney diseases.

75 D24-Siglec pathway in discriminating between DAMPs and PAMPs.

76 , donor DCs in the GI tract are activated by DAMP/PAMP signals in the colon that gain access to the l

77 eristics, and signaling pathways elicited by DAMPs will be critically evaluated.

78 ve immune responses are triggered in vivo by DAMPs induced by tumor progression are not well characte

79 we will review the contribution of candidate DAMPs and their receptors, and discuss the evidence for

80 lthough LRRC8A was dispensable for canonical DAMP-dependent NLRP3 activation, this was still sensitiv

81 A12; a potent mucosa- and neutrophil-derived DAMP.

82 ytotoxic anticancer treatment, tumor-derived DAMPs (damage-associated molecular patterns) can be sens

83 danger-associated molecular patterns (i.e., DAMPs) to activate TLRs and the innate immune system.

84 ATP acts as an effective DAMP when released into extracellular space from damaged

85 Additionally, elevated DAMP protein levels in islet infusion bag exosomes corre

86 MRP8/MRP14 is an endogenous DAMP involved in various inflammatory diseases, though i

87 that the production of HMGB1, an established DAMP released by dying cells, was critical for tumor pro

88 Further evidence for DAMP signaling in behavioral responses is provided by ev

89 heir receptors, and discuss the evidence for DAMPs as tumor-promoting and anti-tumor effectors, as we

90 luble RAGE, an inhibitory decoy receptor for DAMPs.

91 These results identify a novel role for DAMPs and AMPs in the stimulation of repair and highligh

92 culture conditions, and it is not known how DAMPs signal under disease relevant conditions such as a

93 fecting activation, some recently identified DAMP receptors control specialised DC functions such as

94 tumors, triggers hallmark immunostimualtory DAMP release (e.g., calreticulin, HSP70, and HMGB1); how

95 poise the adjuvanticity of immunostimulatory DAMPs.

96 TLR9 and P2X(7) are important DAMP receptors upstream of inflammasome activation, and

97 sly unreported, show PG's ability to inhibit DAMP-induced TLR activation, thereby reducing inflammato

98 prostaglandin E(2) release as an inhibitory DAMP to counterpoise the adjuvanticity of immunostimulat

99 nce between immunostimulatory and inhibitory DAMPs could determine the outcome of drug-induced ICD an

100 initiated by the lipid-soluble azo initiator DAMP, dimethyl 2,2'-azobis (2-methylpropionate), while Q

101 Cryopyrin activation and microbial ligand-, DAMP-, and crystal-induced IL-1beta secretion.

102 Recent evidence has indicated that the major DAMP driving host antitumor immune responses is tumor-de

103 Many DAMPs represent intracellular contents that are released

104 Targeting mito-DAMP release from hepatocytes and/or modulating the phag

105 Circulating mito-DAMPs are markedly increased in human patients with non-

106 The release of mito-DAMPs is controlled by efferocytosis of dying hepatocyte

107 d damage-associated molecular patterns, mito-DAMPs) triggers a potent inflammatory response, but thei

108 ouse strain system, we demonstrate that mito-DAMPs released from injured hepatocyte mitochondria (wit

109 Mitochondrial DAMPs and PAMPs share the same pattern recognition recep

110 Mitochondrial DAMPs such as mtDNA bind specific pattern recognition re

111 e we show that injury releases mitochondrial DAMPs (MTDs) into the circulation with functionally impo

112 disruption by trauma releases mitochondrial DAMPs with evolutionarily conserved similarities to bact

113 the hypothesis that acidic conditions modify DAMP-induced IL-1beta release from cultured primary mous

114 nger-associated molecular pattern molecules (DAMPs) and infiltration of inflammatory cells.

115 mage-associated molecular pattern molecules (DAMPs) are cell-derived and initiate and perpetuate immu

116 mage-associated molecular pattern molecules (DAMPs) including AGEs, HMGB1, S100s, and DNA.

117 mage-associated molecular pattern molecules (DAMPs) such as S100 proteins and high-mobility group box

118 mage-Associated Molecular Pattern molecules (DAMPs) suggested that, at best, early application at a s

119 Moreover, DAMPs may incite distinct downstream cellular responses

120 s who developed MODS also had elevated mtDNA DAMP levels compared with those who did not (32.57 +/- 0

121 er threshold cycles indicate increased mtDNA DAMP content.

122 with SIRS had significantly increased mtDNA DAMP levels in all 4 sequences examined (32.14 +/- 0.90

123 Patients with above-median mtDNA DAMP levels had a significantly elevated relative risk f

124 determine relationships between plasma mtDNA DAMP levels and the occurrence of systemic inflammatory

125 MtDNA DAMPs were quantified as PCR threshold cycle number.

126 tion; however, the link between plasma mtDNA DAMPs and outcome in severely injured human subjects has

127 rst observational evidence that plasma mtDNA DAMPs is associated with the evolution of SIRS, MODS, an

128 ions in animal models demonstrate that mtDNA DAMPs contribute to organ dysfunction; however, the link

129 cute myeloid leukemia (AML) exposed multiple DAMPs, including calreticulin (CRT), heat-shock protein

130 ted extracellular release of the necroptotic DAMP, IL-33, and reduced Myd88-dependent inflammation.

131 l regulator of hypotonicity-induced, but not DAMP-induced, NLRP3 inflammasome activation.

132 ese data point to what we believe is a novel DAMP-mediated process that allows osteoclast activation

133 ecroptosis, and increased release of nuclear DAMPs compared with controls.

134 Additionally, the adsorption of DAMP adheres to the Langmuir isotherm.

135 eveal that histones represent a new class of DAMP molecules and serve as a crucial link between initi

136 mice, thereby underscoring the importance of DAMP-mediated activities in pathophysiological condition

137 een shown to recognize a broad collection of DAMPs exclusively.

138 However, the implication of DAMPs in apical and marginal periodontitis is unknown.

139 ical data have established the importance of DAMPs, which signal through innate pattern recognition r

140 On the other hand, cell death and release of DAMPs may also trigger chronic inflammation and, thereby

141 IRGM regulates necroptosis and release of DAMPs to induce gastrointestinal inflammation, linking I

142 Here we focus on the role of DAMPs and their putative receptors in the pathogenesis o

143 tention to the possible pathological role of DAMPs as an immune consequence of thermal injury.

144 A growing understanding of the role of DAMPs in directing the immune response to transplantatio

145 nce of suitable models, the relative role of DAMPs released because of necrosis or leukocyte activati

146 nate pattern recognition receptors (PRRs) or DAMP-specific receptors, in regulating the alloresponse

147 nger-associated molecular patterns (PAMPs or DAMPs).

148 nally, we detected increased levels of other DAMPs, such as high mobility group box 1 (HMGB1) and mit

149 In this review, we outline DAMPs and their function in thermal injury, shedding lig

150 wever, bsk5 plants were not affected in PAMP/DAMP activation of mitogen-activated protein kinases and

151 s induced by the elf18, pep1, and flg22 PAMP/DAMPs, including resistance to P. syringae and B. cinere

152 r damage-associated molecular patterns (PAMP/DAMPs) and initiate pattern-triggered immunity (PTI).

153 RGM expression, which is increased by PAMPs, DAMPs, and microbes, can suppress the pro-inflammatory r

154 t methods that can be used to identify PAMPs/DAMPs and PRRs.

155 Here, we comprehensively review known PAMPs/DAMPs recognized by plants as well as the plant PRRs des

156 However, in contrast to other known PAMPs/DAMPs, cellobiose stimulates neither detectable reactive

157 /damage-associated molecular patterns (PAMPs/DAMPs) through pattern recognition receptors (PRRs) such

158 ct as a danger-associated molecular pattern (DAMP) and elicit strong inflammatory responses.

159 he mito-damage-associated molecular pattern (DAMP) cardiolipin can be detected in the lungs.

160 rceived danger-associated molecular pattern (DAMP) in primary adult hippocampal neurons, while Abeta

161 totypic damage-associated molecular pattern (DAMP) molecule and has been implicated in several inflam

162 the key damage-associated molecular pattern (DAMP) molecule high-mobility group box 1 (HMGB1) and its

163 P) is a damage-associated molecular pattern (DAMP) molecule which stimulates proinflammatory cytokine

164 art via danger-associated molecular pattern (DAMP) molecules, such as high mobility group box 1 prote

165 ease of damage-associated molecular pattern (DAMP) molecules.

166 ellular damage-associated molecular pattern (DAMP) molecules.

167 nstream damage-associated molecular pattern (DAMP) pathway activation in vivo and in vitro and in pat

168 tion of damage-associated molecular pattern (DAMP) receptors and a cytosolic complex termed the infla

169 mediate damage-associated molecular pattern (DAMP) response including elevations in heat-shock protei

170 iversal danger-associated molecular pattern (DAMP) signal; however, the mechanisms of self-DNA releas

171 (PAMP)/damage-associated molecular pattern (DAMP) signals derived from conditioning and intestinal m

172 ts as a danger-associated molecular pattern (DAMP) that initiates helminth-induced type 2 immune resp

173 ts as a danger-associated molecular pattern (DAMP) that is potently proinflammatory.

174 ng as a danger-associated molecular pattern (DAMP) that stimulates cytokine production in neighboring

175 ectious damage-associated molecular pattern (DAMP), heparan sulfate (HS),(1) aggravates graft-versus-

176 id is a damage-associated molecular pattern (DAMP), released from ischemic tissues and dying cells wh

177 P) is a damage-associated molecular pattern (DAMP).

178 and pathogen-associated molecular patterns (DAMP and PAMP, respectively) through pattern recognition

179 creted danger-associated molecular patterns (DAMP), including ATP and HMGB1, and functioned effective

180 ted by damage-associated molecular patterns (DAMP).

181 and pathogen-associated molecular patterns (DAMPs and PAMPs).

182 al DNA damage-associated molecular patterns (DAMPs) accumulate in the circulation after severe injury

183 ), and damage-associated molecular patterns (DAMPs) activate families of pattern recognition receptor

184 danger/damage associated molecular patterns (DAMPs) and a reduction in immunoinhibitory miRNA, which

185 ion of damage-associated molecular patterns (DAMPs) and a response that includes secretion of cytokin

186 ure of damage-associated molecular patterns (DAMPs) and cytokines/chemokines.

187 abolic damage-associated molecular patterns (DAMPs) and discuss potential targets for therapeutic int

188 act as damage-associated molecular patterns (DAMPs) and interact with pattern recognition receptors t

189 Damage-associated molecular patterns (DAMPs) are considered key inducers of sterile inflammati

190 Damage-associated molecular patterns (DAMPs) are critical mediators of information concerning

191 Damage-associated molecular patterns (DAMPs) are molecules released by dead cells that trigger

192 Damage-associated molecular patterns (DAMPs) are released in response to cell death and stress

193 hrough danger associated molecular patterns (DAMPs) as a response to an insult (systemic inflammatory

194 ase of damage-associated molecular patterns (DAMPs) by dying cancer cells.

195 ion by danger associated molecular patterns (DAMPs) can be deleterious to the host.

196 llular damage-associated molecular patterns (DAMPs) can shape the immune response.

197 ing as damage-associated molecular patterns (DAMPs) for pattern recognition receptors (PRRs) may repr

198 L) are danger-associated molecular patterns (DAMPs) generated in response to infection that can preve

199 s from danger-associated molecular patterns (DAMPs) in the initiation of type 2 immune responses.

200 ncoded damage-associated molecular patterns (DAMPs) induce inflammatory gene expression.

201 ase of damage-associated molecular patterns (DAMPs) is a characteristic feature of most advanced tumo

202 ted by damage-associated molecular patterns (DAMPs) like HMGB1.

203 zed as damage-associated molecular patterns (DAMPs) or pattern-associated molecular patterns (PAMPs)

204 Ps) or damage-associated molecular patterns (DAMPs) recognized by plant PRRs induces both local and s

205 ing to damage-associated molecular patterns (DAMPs) released by injured host cells unleashes an infla

206 sense damage-associated molecular patterns (DAMPs) released by necrotic osteocytes via macrophage-in

207 detect danger-associated molecular patterns (DAMPs) released from cells damaged during ischemia-reper

208 ns and damage-associated molecular patterns (DAMPs) released from damaged/necrotic host cells are cru

209 uch as damage-associated molecular patterns (DAMPs) released from injured cells to stimulate innate i

210 ogenic damage-associated molecular patterns (DAMPs) released into the circulation from football-induc

211 iverse damage-associated molecular patterns (DAMPs) such as extracellular ATP, excess glucose, cerami

212 nous 'damage'-associated molecular patterns (DAMPs) that activate innate immunity.

213 uch as damage-associated molecular patterns (DAMPs) that elicit localised inflammation in the injured

214 s) and danger-associated molecular patterns (DAMPs) to influence the activation and trafficking of DC

215 ensing damage associated molecular patterns (DAMPs) to sensing all particulate matter irrespective of

216 ept of damage-associated molecular patterns (DAMPs) was proposed to describe plant elicitors like oli

217 Damage-associated molecular patterns (DAMPs) were decreased in kidney tissue after 6 hours NMP

218 ltiple damage-associated molecular patterns (DAMPs) which include intracellular formation of reactive

219 gands, danger-associated molecular patterns (DAMPs), and crystals.

220 ase of damage-associated molecular patterns (DAMPs), and progressing through innate and adaptive immu

221 AMPs), danger-associated molecular patterns (DAMPs), and the more recent discovery of the role of the

222 ) and damaged-associated molecular patterns (DAMPs), and they are involved in the regulation of innat

223 ls, or damage-associated molecular patterns (DAMPs), are generated in response to cell stress and act

224 o host danger-associated molecular patterns (DAMPs), but not to microbial pathogen-associated molecul

225 rosis, damage-associated molecular patterns (DAMPs), cause inflammation.

226 termed damage-associated molecular patterns (DAMPs), have been proposed to activate dendritic cells (

227 to as danger associated molecular patterns (DAMPs), including those triggered by crystalline particu

228 become damage-associated molecular patterns (DAMPs), promoting inflammation and coagulation.

229 MPs or damage-associated molecular patterns (DAMPs), such as uric acid or ATP, via NLRP3, which leads

230 er- or damage-associated molecular patterns (DAMPs), which are also perceived by PRRs to modulate PTI

231 called danger-associated molecular patterns (DAMPs), which initiate immune responses through pattern-

232 ase of damage-associated molecular patterns (DAMPs), which recruit and activate dendritic cells (DCs)

233 ted by damage-associated molecular patterns (DAMPs).

234 nse to damage-associated molecular patterns (DAMPs).

235 ing as damage-associated molecular patterns (DAMPs).

236 ase of danger-associated molecular patterns (DAMPs).

237 re the damage-associated molecular patterns (DAMPs).

238 Ps) or damage-associated molecular patterns (DAMPs).

239 ion of damage-associated molecular patterns (DAMPs).

240 to as damage-associated molecular patterns (DAMPs).

241 called danger associated molecular patterns (DAMPs).

242 ted by damage-associated molecular patterns (DAMPs).

243 resent danger-associated molecular patterns (DAMPs).

244 termed damage-associated molecular patterns (DAMPs).

245 own as damage-associated molecular patterns (DAMPs).

246 erived damage-associated molecular patterns (DAMPs).

247 uch as damage-associated molecular patterns (DAMPs).

248 luding damage-associated molecular patterns (DAMPs).

249 ase of damage-associated molecular patterns (DAMPs).

250 - or pathogen-associated molecular patterns (DAMPs/PAMPs) from blood with high efficiency (92-99%).

251 ived "damage-associated molecular patterns" (DAMPs), RAGE has been shown to recognize a broad collect

252 (or damage)-associated molecular patterns" (DAMPs).

253 s of 'danger associated molecular patterns' (DAMPs), against which a concerted innate immune response

254 ounds (damage-associated molecular patterns, DAMPs) such as peptides released from cells upon attack.

255 lled "damage-associated molecular patterns," DAMPs), as they die in the context of failing adaptive r

256 cells (damage-associated molecular patterns; DAMPs) activate cellular receptors leading to downstream

257 A9 as a representative antimicrobial peptide DAMP.

258 density-associated mutation-rate plasticity (DAMP) at multiple loci in both eukaryotes and bacteria,

259 damage-associated molecular pattern protein (DAMP) and Toll-like receptor 4 (TLR4) ligand.

260 physema development and progression via RAGE-DAMP signaling.

261 ross-talk with various non-immune receptors, DAMPs determine the downstream signaling outcome of sept

262 ating into injured tissues tonically release DAMPs, including the high mobility group box 1 protein (

263 ent with the notion that osteolysis releases DAMPs from bone matrix, pharmacologic inhibition of bone

264 H stage and suggest that targeting RELMalpha/DAMP-driven macrophages may offer a promising strategy t

265 ity and, potentially, tolerance that renders DAMPs nonredundant players in responses to both sterile

266 es stromal activation with deployment of RNA DAMPs that promote aggressive features of cancer.

267 Since some DAMPs confer tissue-specific activation of the inflammas

268 a simple, reliable, sensitive, and specific DAMP assay can be well suited for rapid nucleic acid det

269 of defense against atherosclerosis-specific DAMPs, and engage adaptive immune responses, provided by

270 Kidney-specific DAMPs include crystals and uromodulin released by renal

271 h, but the relative contribution of specific DAMPs, including high-mobility group box 1 (HMGB1), is i

272 protein recognize common oxidation-specific DAMPs, such as oxidized phospholipids and oxidized chole

273 s as well as the existence of tumor-specific DAMPs.

274 ll-like receptors (TLRs) that recognize such DAMPs and PAMPs, or the downstream effector molecules th

275 As such, DAMPs may exert protective functions by alerting the imm

276 ablishes HMGB1 as a bona fide and targetable DAMP that selectively triggers a neutrophil-mediated inj

277 Nonetheless, in each domain tested, DAMP requires proteins scavenging the mutagenic oxidised

278 2019) reports that DAMP-induced sterile brain inflammation from stroke is a

279 However, recent evidence revealed that DAMPs also trigger re-epithelialization upon kidney inju

280 Thus, these discoveries suggest that DAMPs drive not only immune injury but also kidney regen

281 Recent evidence suggests that DAMPs may also have a key role in the development of can

282 The DAMP extracellular ATP (eATP) released by dying myofiber

283 As an application demonstration, the DAMP assay was used to detect HIV-1 DNA/RNA and Escheric

284 eficient in the IL-1 family receptor for the DAMP, IL-33 (called ST2), displayed reduced intestinal T

285 More importantly, the DAMP assay showed ultralow background signals without fa

286 oy were associated with up-regulation of the DAMP-related signaling pathway via Nrf2.

287 ur opinion that these function to remove the DAMP (ATP) released by host cells in response to schisto

288 nase and aspartate aminotransferase, and the DAMPs interleukin 18 and HMGB1 were reduced.

289 These DAMPs are sensed by a pattern recognition receptor calle

290 Historically, these DAMPs have been shown to be pro-inflammatory in nature.

291 growth factor production in response to this DAMP.

292 hibition of proteostasis both contributed to DAMP release.

293 onstrated recently that the host response to DAMP is controlled by a DAMP-CD24-Siglec axis.

294 se initiated by the accumulation of OSE type DAMPs and perpetuated by maladaptive response of the inn

295 tein (HMGB1), but the receptor(s) underlying DAMP signaling have not been identified.

296 ricted receptor specific for an unidentified DAMP that is exposed by necrotic cells and is necessary

297 In this study, we examined whether DAMP-receptors and the inflammasome provide the link bet

298 Widespread DAMP, which we manipulate genetically in disparate organ

299 Concurrent with DAMP presentation, significant elevations in proinflamma

300 LPS-primed glial cells were stimulated with DAMPs under acidic conditions (pH 6.2), the predominant